CPL 976 MMAE
Alternative Names: CPL-976-MMAELatest Information Update: 15 Jan 2024
At a glance
- Originator Celon Pharma
- Class Antibodies; Antineoplastics; Drug conjugates; Immunoconjugates
- Mechanism of Action Apoptosis stimulants; Axl receptor tyrosine kinase inhibitors; Mitosis inhibitors; Programmed cell death-1 ligand-1 inhibitors; Tubulin inhibitors; Tubulin polymerisation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Solid tumours